|
US4911920A
(en)
|
1986-07-30 |
1990-03-27 |
Alcon Laboratories, Inc. |
Sustained release, comfort formulation for glaucoma therapy
|
|
FR2588189B1
(fr)
|
1985-10-03 |
1988-12-02 |
Merck Sharp & Dohme |
Composition pharmaceutique de type a transition de phase liquide-gel
|
|
DK0495421T3
(da)
|
1991-01-15 |
1996-12-09 |
Alcon Lab Inc |
Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
|
|
US5212162A
(en)
|
1991-03-27 |
1993-05-18 |
Alcon Laboratories, Inc. |
Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
|
|
CA2115792C
(en)
*
|
1993-03-05 |
2005-11-01 |
David J. Mayer |
Method for the treatment of pain
|
|
US5352683A
(en)
*
|
1993-03-05 |
1994-10-04 |
Virginia Commonwealth University Medical College Of Virginia |
Method for the treatment of chronic pain
|
|
SE501482C2
(sv)
|
1993-06-24 |
1995-02-27 |
Leiras Oy |
Komposition för topisk administration av bispilokarpinsyradiestrar till ögat i form av en vattenlösning
|
|
DE69425948T2
(de)
|
1993-12-06 |
2001-02-22 |
Takeda Chemical Industries, Ltd. |
Zusammensetzung mit verbesserter Wasserlöslichkeit, enthaltend eine Wasserunlösliche oder an Wasser schwerunlösliche Verbindung
|
|
WO1997007750A1
(en)
*
|
1995-08-30 |
1997-03-06 |
Weg Stuart L |
Administration of ketamine to manage pain and to reduce drug dependency
|
|
ES2210769T3
(es)
|
1997-06-13 |
2004-07-01 |
Cydex Inc. |
Compuesto con vida de almacenamiento prolongada que comprende ciclodextrina y medicamentos y promedicamentos que se descomponen en componentes insolubles en agua.
|
|
ES2257795T3
(es)
|
1997-07-01 |
2006-08-01 |
Pfizer Products Inc. |
Procedimiento para producir una ciclodextrina.
|
|
US6699849B1
(en)
|
1998-02-23 |
2004-03-02 |
Cyclops, Ehf. |
Cyclodextrin complexes of benzodiazepines
|
|
ES2288018T3
(es)
*
|
1998-04-03 |
2007-12-16 |
Novartis Vaccines And Diagnostics, Inc. |
Formulaciones inyectables de igf que contienen succinato como tampon.
|
|
IT1303735B1
(it)
|
1998-11-11 |
2001-02-23 |
Falorni Italia Farmaceutici S |
Acidi ialuronici reticolati e loro usi medici.
|
|
CN1172908C
(zh)
|
1999-12-10 |
2004-10-27 |
中国科学院上海药物研究所 |
N-取代苄基或苯基芳香磺酰胺化合物及其用途
|
|
US6348777B1
(en)
|
2000-02-29 |
2002-02-19 |
Alaris Medical Systems, Inc. |
Power management system
|
|
EP1383445A4
(en)
*
|
2001-03-20 |
2005-04-13 |
Cydex Inc |
FORMULATIONS WITH PROPOFOL AND A SULFOALKYL ETHER CYCLODEXTRIN
|
|
US7034013B2
(en)
*
|
2001-03-20 |
2006-04-25 |
Cydex, Inc. |
Formulations containing propofol and a sulfoalkyl ether cyclodextrin
|
|
US6869939B2
(en)
*
|
2002-05-04 |
2005-03-22 |
Cydex, Inc. |
Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
|
|
NZ537995A
(en)
|
2002-08-20 |
2007-11-30 |
Bristol Myers Squibb Co |
Inclusion complex of aripiprazole in a substituted b-cyclodextrin
|
|
AU2004260884B2
(en)
|
2003-07-22 |
2009-11-19 |
Crucell Holland B.V. |
Binding molecules against SARS-coronavirus and uses thereof
|
|
KR20060115350A
(ko)
|
2003-09-02 |
2006-11-08 |
화이자 프로덕츠 인크. |
지프라시돈의 지속 방출형 투여 형태
|
|
KR20060113737A
(ko)
*
|
2003-12-22 |
2006-11-02 |
쉐링 코포레이션 |
약제학적 조성물
|
|
DE102005041860A1
(de)
|
2005-09-02 |
2007-03-08 |
Schering Ag |
Nanopartikulärer Einschluss- und Ladungskomplex für pharmazeutische Formulierungen
|
|
CN1939298A
(zh)
|
2005-09-29 |
2007-04-04 |
中国科学院上海药物研究所 |
硫酸舒欣啶固体和靶向制剂及其制备方法
|
|
KR20080080087A
(ko)
|
2005-09-30 |
2008-09-02 |
티티아이 엘뷰 가부시키가이샤 |
신규 약학 담체를 이용한 경피 약물 전달시스템, 장치 및방법
|
|
JP2009530385A
(ja)
|
2006-03-22 |
2009-08-27 |
マウント シナイ スクール オブ メディシン |
うつ病の治療のためのケタミンの鼻内投与
|
|
EP2139848A1
(en)
*
|
2007-04-26 |
2010-01-06 |
Auspex Pharmaceuticals, Inc. |
Deuterium labelled ketamine
|
|
CA2698038A1
(en)
|
2007-07-26 |
2009-01-29 |
Entra Pharmaceuticals Inc. |
Systems and methods for delivering drugs
|
|
US8492538B1
(en)
|
2009-06-04 |
2013-07-23 |
Jose R. Matos |
Cyclodextrin derivative salts
|
|
JP5785175B2
(ja)
|
2009-10-26 |
2015-09-24 |
石葯集団中奇制葯技▲術▼（石家庄）有限公司 |
スルホブチルエーテルシクロデキストリン塩を含有する内水相を有するリポソーム
|
|
US20120295893A1
(en)
|
2009-12-14 |
2012-11-22 |
Coeruleus Ltd. |
Compositions and methods of counteracting residual sedative effects of sleep/ hypnotic drugs
|
|
ITRM20100630A1
(it)
|
2010-12-03 |
2012-06-04 |
Dyepower |
Procedimento di sintesi di complessi precursori e sensibilizzatori del biossido di titanio basati su complessi polipiridinici di rutenio.
|
|
EP2653479B1
(en)
|
2010-12-16 |
2015-12-02 |
Sumitomo Seika Chemicals Co. Ltd. |
Method for producing pseudopolyrotaxane aqueous dispersion
|
|
AU2012221704B2
(en)
|
2011-02-23 |
2013-12-05 |
Coeruleus Ltd. |
Flumazenil complexes, compositions comprising same and uses thereof
|
|
JP6296985B2
(ja)
*
|
2011-10-14 |
2018-03-20 |
ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
うつ病及び神経障害性疼痛の治療における（２ｒ，６ｒ）−ヒドロキシノルケタミン、（ｓ）−デヒドロノルケタミン及び他の（ｒ，ｓ）−ケタミンの立体異性デヒドロ及びヒドロキシル化代謝生成物の使用
|
|
JP2015512418A
(ja)
*
|
2012-03-30 |
2015-04-27 |
ザ ジェネラル ホスピタル コーポレイション |
うつ病の治療におけるスコポラミンおよびケタミンを含む組成物
|
|
US20130296437A1
(en)
|
2012-05-04 |
2013-11-07 |
E-Therapeutics Plc |
Treatment of Depression
|
|
CN104520326A
(zh)
|
2012-06-21 |
2015-04-15 |
Ucb医药有限公司 |
药物制剂
|
|
US10124940B2
(en)
|
2012-09-11 |
2018-11-13 |
Zolo Solutions, Inc. |
Systems, methods, and devices for dispensing one or more substances
|
|
WO2014121235A2
(en)
|
2013-02-01 |
2014-08-07 |
Zoneone Pharma, Inc. |
Transformation of drug cyclodextrin complex compositions into compositions of mixtures of lipid vesicle encapsulated drug and cyclodextrin drug complexes
|
|
US9446186B2
(en)
|
2013-03-01 |
2016-09-20 |
Bigfoot Biomedical, Inc. |
Operating an infusion pump system
|
|
CN105437676B
(zh)
|
2014-08-14 |
2020-03-24 |
上海利统生化制品有限公司 |
用于阻碍植物乙烯反应的层合物及其制备方法
|
|
FR3032353B1
(fr)
|
2015-02-06 |
2017-03-10 |
Jacques Seguin |
Composition pharmaceutique et dispositif pour le traitement de la douleur
|
|
CN108601891B
(zh)
|
2016-01-12 |
2022-05-13 |
输液创新有限公司 |
输注设备
|
|
AU2017250086A1
(en)
*
|
2016-04-11 |
2018-09-20 |
Clexio Biosciences Ltd. |
Deuterated ketamine derivatives
|
|
WO2017218918A1
(en)
|
2016-06-17 |
2017-12-21 |
Ys Pharmtech |
Stabilization of epinephrine formulations
|
|
DE102016014603A1
(de)
|
2016-06-30 |
2018-01-04 |
Thomas Herkenroth |
Synthetisches Ayahuasca
|
|
SG11201901147TA
(en)
|
2016-08-25 |
2019-03-28 |
Validose Inc |
System and method for controlled medical therapy
|
|
BR102017016440A2
(pt)
|
2017-07-31 |
2019-03-19 |
Universidade Federal Do Rio Grande Do Sul |
Composição para terapia gênica do sistema nervoso central, processo de obtenção e uso da mesma
|
|
EP3498266A1
(en)
|
2017-12-15 |
2019-06-19 |
Bayer Consumer Care AG |
Formulations of copanlisib
|
|
US20200384188A1
(en)
|
2017-11-14 |
2020-12-10 |
Bexson Biomedical, Inc. |
Systems, devices, formulations and methods for controlled drug delivery
|
|
CN111330019B
(zh)
|
2018-12-18 |
2022-03-15 |
中国人民解放军第二军医大学 |
氟马西尼包合物及其制备方法和应用
|
|
EP3968979B1
(en)
*
|
2019-05-15 |
2026-07-01 |
Bexson Biomedical, Inc. |
KETAMINE FORMULATION FOR SUBCUTANEOUS INJECTION
|
|
US12576026B2
(en)
|
2020-07-08 |
2026-03-17 |
Extrovis Ag |
Formulations of nebivolol
|
|
EP4247340A4
(en)
|
2020-11-18 |
2024-10-02 |
Bexson Biomedical, Inc. |
COMPLEXING SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS
|
|
EP4247386A4
(en)
|
2020-11-18 |
2024-12-18 |
Bexson Biomedical, Inc. |
FLUMAZENIL FORMULATIONS FOR SUBCUTANEOUS INJECTION AND METHODS OF TREATMENT USING GABA RECEPTOR MODULATORS
|
|
EP4525916A4
(en)
|
2022-05-18 |
2026-05-20 |
Bexson Biomedical Inc |
LOW STOICHIOMETRIC RATIO SALT FORMULATIONS FOR COMPLEXING AGENTS OF PHARMACEUTICAL COMPOUNDS
|
|
WO2025111482A1
(en)
|
2023-11-22 |
2025-05-30 |
Bexson Biomedical, Inc. |
Complexing agent salt formulations of pharmaceutical compounds at low stoichiometric ratios
|